These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 7903394)
1. D1 and D2 dopamine receptor turnover and D2 messenger RNA levels in the neuroleptic-responsive and the neuroleptic nonresponsive lines of mice. Qian Y; Hitzemann B; Yount GL; White JD; Hitzemann R J Pharmacol Exp Ther; 1993 Dec; 267(3):1582-90. PubMed ID: 7903394 [TBL] [Abstract][Full Text] [Related]
2. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice. Hitzemann R; Qian Y; Hitzemann B J Pharmacol Exp Ther; 1993 Jul; 266(1):431-8. PubMed ID: 8101223 [TBL] [Abstract][Full Text] [Related]
3. D1 and D2 dopamine receptor distribution in the neuroleptic nonresponsive and neuroleptic responsive lines of mice, a quantitative receptor autoradiographic study. Qian Y; Hitzemann B; Hitzemann R J Pharmacol Exp Ther; 1992 Apr; 261(1):341-8. PubMed ID: 1532835 [TBL] [Abstract][Full Text] [Related]
4. Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine. Morissette M; Goulet M; Calon F; Falardeau P; Blanchet PJ; Bédard PJ; Di Paolo T Mol Pharmacol; 1996 Nov; 50(5):1073-9. PubMed ID: 8913337 [TBL] [Abstract][Full Text] [Related]
5. Unilateral ibotenic acid lesion of the caudate putamen results in D2 receptor alterations on the contralateral side. Narang N; Hunt ME; Pundt LL; Alburges ME; Wamsley JK Exp Neurol; 1993 May; 121(1):40-7. PubMed ID: 8495710 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678 [TBL] [Abstract][Full Text] [Related]
8. Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats. Giardino L Brain Res; 1996 May; 720(1-2):235-8. PubMed ID: 8782918 [TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum. Zou LL; Cai ST; Jin GZ Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137 [TBL] [Abstract][Full Text] [Related]
10. On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. Kanes SJ; Hitzemann BA; Hitzemann RJ J Pharmacol Exp Ther; 1993 Oct; 267(1):538-47. PubMed ID: 7901398 [TBL] [Abstract][Full Text] [Related]
11. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I; Ghorayeb I; Normand E; Bloch B J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753 [TBL] [Abstract][Full Text] [Related]
12. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
13. Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease. Weeks RA; Piccini P; Harding AE; Brooks DJ Ann Neurol; 1996 Jul; 40(1):49-54. PubMed ID: 8687191 [TBL] [Abstract][Full Text] [Related]
14. Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy. Hitzemann B; Dains K; Kanes S; Hitzemann R J Pharmacol Exp Ther; 1994 Nov; 271(2):969-76. PubMed ID: 7965819 [TBL] [Abstract][Full Text] [Related]
15. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577 [TBL] [Abstract][Full Text] [Related]
16. Localization of dopaminergic markers in the human subthalamic nucleus. Augood SJ; Hollingsworth ZR; Standaert DG; Emson PC; Penney JB J Comp Neurol; 2000 May; 421(2):247-55. PubMed ID: 10813785 [TBL] [Abstract][Full Text] [Related]
17. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390. Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879 [TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Augood SJ; Faull RL; Emson PC Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732 [TBL] [Abstract][Full Text] [Related]
19. Genetic interdependence of adenosine and dopamine receptors: evidence from receptor knockout mice. Short JL; Ledent C; Borrelli E; Drago J; Lawrence AJ Neuroscience; 2006 May; 139(2):661-70. PubMed ID: 16476524 [TBL] [Abstract][Full Text] [Related]
20. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain. Gross J; Andersson K; Chen Y; Müller I; Andreeva N; Herrera-Marschitz M Brain Res Mol Brain Res; 2005 Apr; 134(2):275-81. PubMed ID: 15836923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]